Acute Investment Advisory’s iShares 0-1 Year Treasury Bond ETF SHV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,573
Closed -$394K 21
2025
Q4
$394K Sell
3,573
-435
-11% -$48K 3.81% 8
2025
Q3
$443K Sell
4,008
-803
-17% -$88.6K 3.72% 7
2025
Q2
$531K Sell
4,811
-3,020
-39% -$333K 4.33% 6
2025
Q1
$865K Buy
+7,831
New +$864K 4.35% 6
2024
Q3
Sell
-2,940
Closed -$325K 16
2024
Q2
$325K Sell
2,940
-109,638
-97% -$12.1M 0.19% 13
2024
Q1
$12.4M Buy
112,578
+1,648
+1% +$182K 8.34% 4
2023
Q4
$12.2M Sell
110,930
-2,811
-2% -$310K 7.22% 4
2023
Q3
$12.6M Sell
113,741
-665,323
-85% -$73.3M 7.55% 4
2023
Q2
$86M Buy
779,064
+28,061
+4% +$3.09M 51.72% 1
2023
Q1
$83M Buy
751,003
+115,245
+18% +$12.7M 54.36% 1
2022
Q4
$69.9M Buy
635,758
+529,181
+497% +$58.2M 47.65% 1
2022
Q3
$11.7M Buy
+106,577
New +$11.7M 8.42% 5

Other funds holding SHV

Acute Investment Advisory's SHV Position: Q1 2026 in Review

Acute Investment Advisory sold out of iShares 0-1 Year Treasury Bond ETF (SHV) in Q1 2026, closing a stake of 3,573 shares — an estimated $394K sold.

Acute Investment Advisory first reported a position in SHV in Q3 2022 and held it in 12 quarters. The position peaked at $86M in Q2 2023. 737 funds tracked by Wall St. Rank hold SHV as of Q1 2026.

  • Acute Investment Advisory reported no remaining iShares 0-1 Year Treasury Bond ETF position as of Q1 2026 after selling out during the quarter.
  • Acute Investment Advisory sold 3,573 iShares 0-1 Year Treasury Bond ETF shares in Q1 2026, an estimated $394K.
  • Acute Investment Advisory first reported a position in iShares 0-1 Year Treasury Bond ETF in Q3 2022 and held it in 12 quarters.
  • Acute Investment Advisory's iShares 0-1 Year Treasury Bond ETF position peaked at $86M in Q2 2023.
  • 737 funds tracked by Wall St. Rank held iShares 0-1 Year Treasury Bond ETF as of Q1 2026.

Based on Acute Investment Advisory's 13F filing for Q1 2026, filed 27 Apr 2026.